{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:23Z","timestamp":1787020943408,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NMRPG8K0111"],"award-info":[{"award-number":["NMRPG8K0111"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This study tested the hypothesis that overexpression of cellular prion protein in endothelial progenitor cells (PrPc\n                      <jats:sup>OE<\/jats:sup>\n                      -EPCs), defined as \u201crejuvenated EPCs,\u201d was superior to EPCs for salvaging the critical limb ischemia (CLI) induced after 28-day chronic kidney disease (CKD) induction in rat.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>\n                      Cell viability and flow cytometric analyses of early\/late apoptosis\/total-intracellular ROS\/cell cycle (sub-G1, G2\/M phase) were significantly higher in EPCs\u2009+\u2009H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      than in EPCs that were significantly reversed in PrPc\n                      <jats:sup>OE<\/jats:sup>\n                      -EPCs\u2009+\u2009H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The protein expressions of inflammation (IL-1\u00df\/IL-6\/MMP-9\/p-NF-\u03baB) were significantly increased in EPC\u2009+\u2009TNF-\u03b1 than in EPCs that were significantly reversed in PrPc\n                      <jats:sup>OE<\/jats:sup>\n                      -EPCs\u2009+\u2009TNF-\u03b1 (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Adult-male SD rats (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098\/each group) were categorized into group 1 (sham-operated control), group 2 (CKD\u2009+\u2009CLI), group 3 [CKD\u2009+\u2009CLI\u2009+\u2009EPCs by intravenous (0.6\u2009\u00d7\u200910\n                      <jats:sup>5<\/jats:sup>\n                      )\/intra-muscular (0.6\u2009\u00d7\u200910\n                      <jats:sup>5<\/jats:sup>\n                      ) injections at 3\u00a0h after CLI induction], group 4 (CKD\u2009+\u2009CLI\u2009+\u2009PrPc\n                      <jats:sup>OE<\/jats:sup>\n                      -EPCs\/dose-administration as group 3) and group 5 (CKD\u2009+\u2009CLI\u2009+\u2009si\n                      <jats:italic>Prnp<\/jats:italic>\n                      -EPCs\/dose-administration as group 3). By day 14 after CLI induction, the ratio of ischemia to normal blood flow (INBF) in CLI area was highest in group 1\/lowest in group 2\/significantly higher in group 4 than in groups 3\/5 and significantly higher in group 3 than in group 5 (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Histopathology demonstrated that the angiogenesis (number of small vessels\/CD31\u2009+\u2009cells) exhibited a similar trend, whereas the fibrosis\/kidney injury score exhibited an opposite pattern of INBF among the groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The protein expressions of angiogenesis (SDF-1\u03b1\/VEGF\/CXCR4)\/cell-stress signaling (p-PI3K\/p-Akt\/p-m-TOR) were significantly and progressively increased from groups 1\u20134 that were reversed in group 5 (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The protein expressions of fibrotic (p-Smad3\/TGF-\u00df)\/oxidative-stress (NOX-1\/NOX-2\/oxidized-protein)\/apoptotic (mitochondrial-Bax\/cleaved caspase3\/cleaved PARP)\/mitochondrial-damaged (cytosolic-cytochrome-C) biomarkers displayed an opposite pattern of INBF among the groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      PrPc\n                      <jats:sup>OE<\/jats:sup>\n                      -EPCs were superior to EPCs only therapy for salvaging the CLI.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-022-03119-0","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T07:26:06Z","timestamp":1662362766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rejuvenated endothelial progenitor cells through overexpression of cellular prion protein effectively salvaged the critical limb ischemia in rats with preexisting chronic kidney disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Jui-Po","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei\u2010Hsun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ruei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Pin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-6263","authenticated-orcid":false,"given":"Jiunn-Jye","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"3119_CR1","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","volume":"344","author":"WR Hiatt","year":"2001","unstructured":"WR Hiatt 2001 Medical treatment of peripheral arterial disease and claudication N Engl J Med 344 1608 1621 https:\/\/doi.org\/10.1056\/NEJM200105243442108","journal-title":"N Engl J Med"},{"key":"3119_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","volume":"286","author":"AT Hirsch","year":"2001","unstructured":"AT Hirsch MH Criqui D Treat-Jacobson JG Regensteiner MA Creager JW Olin SH Krook DB Hunninghake AJ Comerota ME Walsh  2001 Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 1317 1324 https:\/\/doi.org\/10.1001\/jama.286.11.1317","journal-title":"JAMA"},{"key":"3119_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0140-6736(01)06351-6","volume":"358","author":"K Ouriel","year":"2001","unstructured":"K Ouriel 2001 Peripheral arterial disease Lancet 358 1257 1264 https:\/\/doi.org\/10.1016\/S0140-6736(01)06351-6","journal-title":"Lancet"},{"key":"3119_CR4","first-page":"123","volume":"12","author":"J Dormandy","year":"1999","unstructured":"J Dormandy L Heeck S Vig 1999 The natural history of claudication: risk to life and limb Semin Vasc Surg 12 123 137","journal-title":"Semin Vasc Surg"},{"key":"3119_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1067\/mva.2001.112210","volume":"33","author":"SC Muluk","year":"2001","unstructured":"SC Muluk VS Muluk ME Kelley JC Whittle JA Tierney MW Webster MS Makaroun 2001 Outcome events in patients with claudication: a 15-year study in 2777 patients J Vasc Surg 33 251 257 https:\/\/doi.org\/10.1067\/mva.2001.112210","journal-title":"J Vasc Surg"},{"key":"3119_CR6","first-page":"77","volume":"45","author":"O Rena","year":"2004","unstructured":"O Rena M Garavoglia M Francini P Bellora A Oliaro C Casadio 2004 Solitary pericardial hydatid cyst J Cardiovasc Surg (Torino) 45 77 80","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"3119_CR7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","volume":"366","author":"JA Dormandy","year":"2005","unstructured":"JA Dormandy B Charbonnel DJ Eckland E Erdmann M Massi-Benedetti IK Moules AM Skene MH Tan PJ Lefebvre GD Murray  2005 Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone clinical trial in macrovascular events): a randomised controlled trial Lancet 366 1279 1289 https:\/\/doi.org\/10.1016\/S0140-6736(05)67528-9","journal-title":"Lancet"},{"key":"3119_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"MJ Sarnak AS Levey AC Schoolwerth J Coresh B Culleton LL Hamm PA McCullough BL Kasiske E Kelepouris MJ Klag  2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention Hypertension 42 1050 1065 https:\/\/doi.org\/10.1161\/01.HYP.0000102971.85504.7c","journal-title":"Hypertension"},{"key":"3119_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"DS Keith GA Nichols CM Gullion JB Brown DH Smith 2004 Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 659 663 https:\/\/doi.org\/10.1001\/archinte.164.6.659","journal-title":"Arch Intern Med"},{"key":"3119_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2004030203","volume":"16","author":"RN Foley","year":"2005","unstructured":"RN Foley AM Murray S Li CA Herzog AM McBean PW Eggers AJ Collins 2005 Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 J Am Soc Nephrol 16 489 495 https:\/\/doi.org\/10.1681\/ASN.2004030203","journal-title":"J Am Soc Nephrol"},{"key":"3119_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","volume":"60","author":"PS Garimella","year":"2012","unstructured":"PS Garimella PD Hart A O'Hare S DeLoach CA Herzog AT Hirsch 2012 Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care Am J Kidney Dis 60 641 654 https:\/\/doi.org\/10.1053\/j.ajkd.2012.02.340","journal-title":"Am J Kidney Dis"},{"key":"3119_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.ackd.2014.07.005","volume":"21","author":"PS Garimella","year":"2014","unstructured":"PS Garimella AT Hirsch 2014 Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes Adv Chronic Kidney Dis 21 460 471 https:\/\/doi.org\/10.1053\/j.ackd.2014.07.005","journal-title":"Adv Chronic Kidney Dis"},{"key":"3119_CR13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/01.asn.0000061776.60146.02","volume":"14","author":"AM O'Hare","year":"2003","unstructured":"AM O'Hare J Feinglass AN Sidawy P Bacchetti RA Rodriguez J Daley S Khuri WG Henderson KL Johansen 2003 Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the department of veterans affairs' national surgical quality improvement program J Am Soc Nephrol 14 1287 1295 https:\/\/doi.org\/10.1097\/01.asn.0000061776.60146.02","journal-title":"J Am Soc Nephrol"},{"key":"3119_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2005111204","volume":"18","author":"K Wattanakit","year":"2007","unstructured":"K Wattanakit AR Folsom E Selvin J Coresh AT Hirsch BD Weatherley 2007 Kidney function and risk of peripheral arterial disease: results from the atherosclerosis risk in communities (ARIC) Study J Am Soc Nephrol 18 629 636 https:\/\/doi.org\/10.1681\/ASN.2005111204","journal-title":"J Am Soc Nephrol"},{"key":"3119_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.05600515","volume":"11","author":"F Luders","year":"2016","unstructured":"F Luders H Bunzemeier C Engelbertz NM Malyar M Meyborg N Roeder K Berger H Reinecke 2016 CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia Clin J Am Soc Nephrol 11 216 222 https:\/\/doi.org\/10.2215\/CJN.05600515","journal-title":"Clin J Am Soc Nephrol"},{"key":"3119_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1358863X09357230","volume":"15","author":"Y Luo","year":"2010","unstructured":"Y Luo X Li J Li X Wang Y Xu Y Qiao D Hu Y Ma 2010 Peripheral arterial disease, chronic kidney disease, and mortality: the Chinese ankle brachial index cohort study Vasc Med 15 107 112 https:\/\/doi.org\/10.1177\/1358863X09357230","journal-title":"Vasc Med"},{"key":"3119_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijcard.2018.03.108","volume":"262","author":"HO Kim","year":"2018","unstructured":"HO Kim JM Kim JS Woo D Choi YG Ko CM Ahn SW Lee JH Lee SH Choi CW Yu  2018 Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: analysis from the K-VIS ELLA registry Int J Cardiol 262 32 37 https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.108","journal-title":"Int J Cardiol"},{"key":"3119_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jvs.2018.05.229","volume":"69","author":"V Ambur","year":"2019","unstructured":"V Ambur P Park JP Gaughan S Golarz F Schmieder P Bemmelen Van E Choi R Dhanisetty 2019 The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia J Vasc Surg 69 491 496 https:\/\/doi.org\/10.1016\/j.jvs.2018.05.229","journal-title":"J Vasc Surg"},{"key":"3119_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.kint.2015.11.020","volume":"89","author":"SC Hung","year":"2016","unstructured":"SC Hung KL Kuo HL Huang CC Lin TH Tsai CH Wang JW Chen SJ Lin PH Huang DC Tarng 2016 Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization Kidney Int 89 574 585 https:\/\/doi.org\/10.1016\/j.kint.2015.11.020","journal-title":"Kidney Int"},{"key":"3119_CR20","doi-asserted-by":"publisher","first-page":"17750","DOI":"10.18632\/oncotarget.14831","volume":"8","author":"MS Lee","year":"2017","unstructured":"MS Lee FY Lee YL Chen PH Sung HJ Chiang KH Chen TH Huang YL Chen JY Chiang TC Yin  2017 Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial Oncotarget 8 17750 17762 https:\/\/doi.org\/10.18632\/oncotarget.14831","journal-title":"Oncotarget"},{"key":"3119_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120548","author":"PY Lin","year":"2018","unstructured":"PY Lin PH Sung SY Chung SL Hsu WJ Chung JJ Sheu SK Hsueh KH Chen RW Wu HK Yip 2018 Hyperbaric oxygen therapy enhanced circulating levels of endothelial progenitor cells and angiogenesis biomarkers, blood flow, in ischemic areas in patients with peripheral arterial occlusive disease J Clin Med https:\/\/doi.org\/10.3390\/jcm7120548","journal-title":"J Clin Med"},{"key":"3119_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrmicro1025","volume":"2","author":"C Weissmann","year":"2004","unstructured":"C Weissmann 2004 The state of the prion Nat Rev Microbiol 2 861 871 https:\/\/doi.org\/10.1038\/nrmicro1025","journal-title":"Nat Rev Microbiol"},{"key":"3119_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1051\/vetres:2007048","volume":"39","author":"V Zomosa-Signoret","year":"2008","unstructured":"V Zomosa-Signoret JD Arnaud P Fontes MT Alvarez-Martinez JP Liautard 2008 Physiological role of the cellular prion protein Vet Res 39 9 https:\/\/doi.org\/10.1051\/vetres:2007048","journal-title":"Vet Res"},{"key":"3119_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.cdd.4401629","volume":"12","author":"X Roucou","year":"2005","unstructured":"X Roucou PN Giannopoulos Y Zhang J Jodoin CG Goodyer A LeBlanc 2005 Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells Cell Death Differ 12 783 795 https:\/\/doi.org\/10.1038\/sj.cdd.4401629","journal-title":"Cell Death Differ"},{"key":"3119_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/22241","volume":"400","author":"C Kuwahara","year":"1999","unstructured":"C Kuwahara AM Takeuchi T Nishimura K Haraguchi A Kubosaki Y Matsumoto K Saeki Y Matsumoto T Yokoyama S Itohara  1999 Prions prevent neuronal cell-line death Nature 400 225 226 https:\/\/doi.org\/10.1038\/22241","journal-title":"Nature"},{"key":"3119_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jnr.10118","volume":"67","author":"DR Brown","year":"2002","unstructured":"DR Brown RS Nicholas L Canevari 2002 Lack of prion protein expression results in a neuronal phenotype sensitive to stress J Neurosci Res 67 211 224 https:\/\/doi.org\/10.1002\/jnr.10118","journal-title":"J Neurosci Res"},{"key":"3119_CR27","doi-asserted-by":"publisher","first-page":"112551","DOI":"10.1016\/j.biopha.2021.112551","volume":"146","author":"CC Yang","year":"2022","unstructured":"CC Yang PH Sung KH Chen HT Chai JY Chiang SF Ko FY Lee HK Yip 2022 Valsartan- and melatonin-supported adipose-derived mesenchymal stem cells preserve renal function in chronic kidney disease rat through upregulation of prion protein participated in promoting PI3K-Akt-mTOR signaling and cell proliferation Biomed Pharmacother 146 112551 https:\/\/doi.org\/10.1016\/j.biopha.2021.112551","journal-title":"Biomed Pharmacother"},{"key":"3119_CR28","doi-asserted-by":"publisher","first-page":"e12536","DOI":"10.1111\/jpi.12536","volume":"66","author":"YT Chen","year":"2019","unstructured":"YT Chen CC Yang PL Shao CR Huang HK Yip 2019 Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway J Pineal Res 66 e12536 https:\/\/doi.org\/10.1111\/jpi.12536","journal-title":"J Pineal Res"},{"key":"3119_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010167","author":"JJ Sheu","year":"2022","unstructured":"JJ Sheu HT Chai JY Chiang PH Sung YL Chen HK Yip 2022 Cellular prion protein is essential for myocardial regeneration but not the recovery of left ventricular function from apical ballooning Biomedicines https:\/\/doi.org\/10.3390\/biomedicines10010167","journal-title":"Biomedicines"},{"key":"3119_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1479-5876-10-244","volume":"10","author":"CL Chang","year":"2012","unstructured":"CL Chang S Leu HC Sung YY Zhen CL Cho A Chen TH Tsai SY Chung HT Chai CK Sun  2012 Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in rat sepsis syndrome induced by cecal puncture and ligation J Transl Med 10 244 https:\/\/doi.org\/10.1186\/1479-5876-10-244","journal-title":"J Transl Med"},{"key":"3119_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijcard.2015.03.137","volume":"201","author":"YL Chen","year":"2015","unstructured":"YL Chen TH Tsai CG Wallace YL Chen TH Huang PH Sung CM Yuen CK Sun KC Lin HT Chai  2015 Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats Int J Cardiol 201 668 683 https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.137","journal-title":"Int J Cardiol"},{"key":"3119_CR32","first-page":"804","volume":"7","author":"TH Huang","year":"2015","unstructured":"TH Huang YT Chen PH Sung HJ Chiang YL Chen HT Chai SY Chung TH Tsai CC Yang CH Chen  2015 Peripheral blood-derived endothelial progenitor cell therapy prevented deterioration of chronic kidney disease in rats Am J Transl Res 7 804 824","journal-title":"Am J Transl Res"},{"key":"3119_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12967-015-0381-8","volume":"13","author":"JJ Sheu","year":"2015","unstructured":"JJ Sheu FY Lee CG Wallace TH Tsai S Leu YL Chen HT Chai HI Lu CK Sun HK Yip 2015 Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia J Transl Med 13 59 https:\/\/doi.org\/10.1186\/s12967-015-0381-8","journal-title":"J Transl Med"},{"key":"3119_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ijcard.2013.11.021","volume":"170","author":"S Leu","year":"2014","unstructured":"S Leu HI Lu CK Sun JJ Sheu YL Chen TH Tsai KH Yeh HT Chai S Chua CY Tsai  2014 Retention of endothelial progenitor cells in bone marrow in a murine model of endogenous tissue plasminogen activator (tPA) deficiency in response to critical limb ischemia Int J Cardiol 170 394 405 https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.021","journal-title":"Int J Cardiol"},{"key":"3119_CR35","doi-asserted-by":"publisher","first-page":"109296","DOI":"10.1016\/j.biopha.2019.109296","volume":"118","author":"FY Lee","year":"2019","unstructured":"FY Lee CW Luo CG Wallace KH Chen JJ Sheu TC Yin HT Chai HK Yip 2019 Direct implantations of erythropoietin and autologous EPCs in critical limb ischemia (CLI) area restored CLI area blood flow and rescued remote AMI-induced LV dysfunction Biomed Pharmacother 118 109296 https:\/\/doi.org\/10.1016\/j.biopha.2019.109296","journal-title":"Biomed Pharmacother"},{"key":"3119_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217887","author":"YC Chen","year":"2020","unstructured":"YC Chen J Sheu JY Chiang PL Shao SC Wu PH Sung YC Li YL Chen TH Huang KH Chen  2020 Circulatory rejuvenated EPCs derived from PAOD patients treated by CD34(+) cells and hyperbaric oxygen therapy salvaged the nude mouse limb against critical ischemia Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms21217887","journal-title":"Int J Mol Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03119-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03119-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03119-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T03:48:01Z","timestamp":1664941681000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03119-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3119"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03119-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Institutional Animal Care and Use Committee at Kaohsiung Chang Gung Memorial Hospital (Affidavit of Approval of Animal Use Protocol No. 2017110201) and performed in accordance with the Guide for the Care and Use of Laboratory Animals, 8th edition (NIH publication No. 85-23, National Academy Press, Washington, DC, USA, revised 2011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}